Nita Amornsiripanitch, MD, 2022 Gayle Brinkenhoff IGNITE Awardee
- “Reducing Barriers to Care in Screening Mammography Among Underserved Populations Through a Quality Improvement Approach”, Journal of the American College of Radiology, September 2022.
Deborah Bartz, MD, MPH, Director of Education
- “Restrictive State Abortion Bans — A Reproductive Injustice”, New England Journal of Medicine, March 2022.
- “Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults”, New England Journal of Medicine, August 2022.
- “Abortion as Essential Health Care and the Critical Role Your Practice Can Play in Protecting Abortion Access”, Obstetrics and Gynecology, August 2022.
Behnood Bikdeli, MD, MS, Tynan Research Fellow, 2021 Specialized Cardiac & Vascular IGNITE Awardee
- “Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study”, Thrombosis Research, June 2022.
- “Direct Oral Anticoagulants vs Vitamin-K Antagonists in Thrombotic Antiphospholipid Syndrome: Meta-analysis of Randomized Controlled Trials”, Journal of the American College of Cardiology, October 2022.
Rohini Dutta, MBBS, 2022 Global Women’s Health Fellow
- “Academic Output in Global Surgery after the Lancet Commission on Global Surgery: A Scoping Review”, World Journal of Surgery, July 2022.
- “Breast Conservative Surgery for Breast Cancer: Indian Surgeon’s Preferences and Factors Influencing Them”, Indian Journal of Surgical Oncology, August 2022.
- “Open Letter to G7 and G20 leaders: resolve global crises to secure our future”, Nature Medicine, August 2022.
Leilah Grant, PhD, Tynan Research Fellow
- “A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women”, Sleep, March 2022.
- “Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women”, Journal of Clinical Endocrinology and Metabolism, July 2022.
Alisa Goldberg, MD, MPH, Director of the Complex Family Planning Fellowship
- “Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location”, Obstetrics and Gynecology, May 2022.
Tianyi Huang, ScD, 2018 WHISPR Awardee
- “Plasma Metabolomic Signature of Early Abuse in Middle-Aged Women”, Psychosomatic Medicine, June 2022.
Hadine Joffe, MD, MSc, Executive Director
- “A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women”, Sleep, March 2022.
- “Enrollment of female participants in United States drug and device phase 1–3 clinical trials between 2016 and 2019”, Contemporary Clinical Trials, April 2022.
- “Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women”, Journal of Clinical Endocrinology and Metabolism, July 2022.
- “Disruption of Sleep Continuity During the Perimenopause: Associations with Female Reproductive Hormone Profiles”, Journal of Clinical Endocrinology and Metabolism, September 2022.
- “Longitudinal associations of psychosocial stressors with menopausal symptoms and well-being among women in midlife”, Menopause, September 2022.
Vesela Kovacheva,MD, PhD, 2021 IGNITE Awardee
- “A survey of pregnant patients’ perspectives on the implementation of artificial intelligence in clinical care”, Journal of the American Medical Informatics Association, October 2022.
Cindy Liu, PhD, Director of Psychosocial Stress, Diversity, and Health
- “Maternal Milk Provision in the Neonatal Intensive Care Unit and Mother-Infant Emotional Connection for Preterm Infants”, Children, February 2022.
- “COVID-19 Pandemic Experiences and Maternal Stress in Neonatal Intensive Care Units”, Children, February 2022.
- “Maternal Self-Efficacy Buffers the Effects of COVID-19–Related Experiences on Postpartum Parenting Stress“, Journal of Obstetric, Gynecologic, and Neonatal Nursing, March 2022.
- “Unmet Prenatal Expectations During the COVID-19 Pandemic”, The American Journal of Maternal/Child Nursing, March 2022.
- “Subjective social status, COVID-19 health worries, and mental health symptoms in perinatal women”, Social Science and Medicine – Population Health, June 2022.
Morteza Mahmoudi, PhD, 2019 Traditional IGNITE Awardee
- “Sex-Specific Silica Nanoparticle Protein Corona Compositions Exposed to Male and Female BALB/c Mice Plasmas”, ACS Bio & Med Chem Au, November 2022.
JoAnn Manson, MD, DrPH, MACP, Scientific Advisor
- “The impact of the COVID-19 pandemic on older women in the Women’s Health Initiative“, J Gerontol A Biol Sci Med Sci, March 2022.
- “Associations between predicted vitamin D status, vitamin D intake, and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity”, The American Journal of Clinical Nutrition, April 2022.
- “Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial”, American Journal of Clinical Nutrition, June 2022.
- “Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial”, American Journal of Clinical Nutrition, June 2022.
- “Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults”, New England Journal of Medicine, July 2022.
- “Vitamin D supplementation and total cancer incidence and mortality by daily vs. infrequent large-bolus dosing strategies: a meta-analysis of randomised controlled trials”, British Journal of Cancer, September 2022.
- “Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo”, JAMA Cardiology, November 2022.
Lidia Minguez-Alarcon, PhD, MPH, 2022 WHISPR Awardee
- “Self-reported menstrual cycle length during reproductive years in relation to menopausal symptoms at midlife in Project Viva”, Menopause, October 2022.
Margo Nathan, MD, 2020 WHISPR Awardee
- “A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women”, Sleep, March 2022.
- “Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women”, Journal of Clinical Endocrinology and Metabolism, July 2022.
- “Disruption of Sleep Continuity During the Perimenopause: Associations with Female Reproductive Hormone Profiles”, Journal of Clinical Endocrinology and Metabolism, September 2022.
Michelle O’Donoghue, MD, MPH
- “Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease”, New England Journal of Medicine, November 2022.
Emily Oken, MD, MPH, ROSA Project Co-Leader
- “Longitudinal associations of psychosocial stressors with menopausal symptoms and well-being among women in midlife”, Menopause, September 2022.
- “Self-reported menstrual cycle length during reproductive years in relation to menopausal symptoms at midlife in Project Viva”, Menopause, October 2022.
Isioma Okolo, MBChB, MRCOG, DTMH, 2020 Global Women’s Health Fellow
- “Training in Ultrasound to Determine Gestational Age in Low- and Middle- Income Countries: A Systematic Review”, Frontiers in Global Women’s Health, March 2022.
- “Shifting global surgery’s center of gravity”, Surgery, June 2022.
Chiamaka Onwuzurike, MD, MPH, 2021 Global Women’s Health Fellow
- “Restrictive State Abortion Bans — A Reproductive Injustice”, New England Journal of Medicine, March 2022.
- “Abortion as Essential Health Care and the Critical Role Your Practice Can Play in Protecting Abortion Access”, Obstetrics and Gynecology, August 2022.
- “Integrating anti-violence efforts into sexual and reproductive health: Reproductive coercion as a case example”, Contraception, November 2022.
Maria Pabon, MD, First.In.Women Fellow
- “Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER”, Circulation, November 2022.
Lydia Pace, MD, MPH, Director of Women’s Health Policy and Advocacy and the Global Women’s Health Fellowship
- “Association of Medicaid Reimbursement for Immediate Postpartum Long-acting Reversible Contraception With Infant Birth Outcomes”, JAMA Pediatrics, March 2022.
- “BRCA1/2 testing among young women with breast cancer in Massachusetts, 2010-2013: An observational study using state cancer registry and All-Payer claims data”, Cancer Medicine, March 2022.
- “False-Positive Results of Mammography Screening in the Era of Digital Breast Tomosynthesis”, JAMA Network Open, March 2022.
- “Downstream Mammary and Extramammary Cascade Services and Spending Following Screening Breast Magnetic Resonance Imaging vs Mammography Among Commercially Insured Women”, JAMA Network Open, April 2022.
- “Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults”, New England Journal of Medicine, August 2022.
Shadab Rahman, PhD, MPH
- “A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women”, Sleep, March 2022.
- “Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women”, Journal of Clinical Endocrinology and Metabolism, July 2022.
Janet Rich-Edwards, ScD, MPH, Director of Lifecourse Epidemiology
- “Associations between predicted vitamin D status, vitamin D intake, and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity”, The American Journal of Clinical Nutrition, April 2022.
- “Enrollment of female participants in United States drug and device phase 1–3 clinical trials between 2016 and 2019”, Contemporary Clinical Trials, April 2022.
- “Longitudinal associations of psychosocial stressors with menopausal symptoms and well-being among women in midlife”, Menopause, September 2022.
Primavera Spagnolo, MD, PhD, Scientific Director, First.In.Women
- “Enrollment of female participants in United States drug and device phase 1–3 clinical trials between 2016 and 2019”, Contemporary Clinical Trials, April 2022.
Wendy Wang, MD, First.In.Women Fellow
- “Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER”, Circulation, November 2022.
Aleta Wiley, MPH, MSc, Director of Research Program Management
- “A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women”, Sleep, March 2022.
- “Enrollment of female participants in United States drug and device phase 1–3 clinical trials between 2016 and 2019”, Contemporary Clinical Trials, April 2022.
- “Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women”, Journal of Clinical Endocrinology and Metabolism, July 2022.
- “Disruption of Sleep Continuity During the Perimenopause: Associations with Female Reproductive Hormone Profiles”, Journal of Clinical Endocrinology and Metabolism, September 2022.
Deborah Bartz, MD, MPH, Director of Education
- “Feedback Focused: A Learner- and Teacher-Centered Curriculum to Improve the Feedback Exchange in the Obstetrics and Gynecology Clerkship”, MedEdPortal | AAMC Journal of Teaching and Learning Resources, March 2021.
- “Reproductive Injustice at the Southern Border and Beyond: An Analysis of Current Events and Hope for the Future”, Women’s Health Issues, April 2021.
Hadine Joffe, MD, MSc, Executive Director
- “Longitudinal Association Between Depressive Symptoms and Multidimensional Sleep Health: The SWAN Sleep Study”, Annals of Behavioral Medicine, January 2021.
- “Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN”, Journal of the American Heart Association, January 2021.
- “A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative”, Menopause, April 2021.
- “Predictors of irritability symptoms in mildly depressed perimenopausal women”, Psychoneuroendocrinology, April 2021.
- “What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy”, Gynecologic Oncology, May 2021.
Cindy Liu, PhD, Director of Psychosocial Stress, Diversity, and Health
- “Risk factors for depression, anxiety, and PTSD symptoms in perinatal women during the COVID-19 Pandemic”, Psychiatry Research, January 2021.
- “Responding to the pressing yet unrecognized needs of student-parents amid the COVID-19 pandemic”, Journals of American College Health, February 2021.
- “Psychological correlates of poor sleep quality among U.S. young adults during the COVID-19 pandemic”, Sleep Medicine, February 2021.
- “Self-Regulatory Development in Children from Chinese Immigrant Families: Evidence for Commonality and Specificity”, Child Development, March 2021.
- “Psychiatric impacts of the COVID-19 global pandemic on U.S. sexual and gender minority young adults”, Psychiatry Research, March 2021.
- “COVID-19-related health worries compound the psychiatric distress experienced by families of high-risk infants”, Journal of Perinatology, March 2021.
- “Health-related quality of life among US young adults during the COVID-19 pandemic: Psychiatric symptoms and emotional experiences to target within clinical”, Annals of Clinical Psychiatry, August 2021.
- “Patient Satisfaction with Virtual-Based Prenatal Care: Implications after the COVID-19 Pandemic”, Maternal and Child Health Journal, August 2021.
- “Psychological risks to mother–infant bonding during the COVID-19 pandemic”, Nature, October 2021.
- “Commentary: Helpline data used to monitor population distress in a pandemic”, Nature, November 2021.
- “Unexpected changes in birth experiences during the COVID-19 pandemic: Implications for maternal mental health”, Archives of Gynecology and Obstetrics, November 2021.
Morteza Mahmoudi, PhD, 2019 Traditional IGNITE Awardee
- “The role of sex as a biological variable in the efficacy and toxicity of therapeutic nanomedicine”, Advanced Drug Delivery Reviews, May 2021.
- “Restoring Endogenous Repair Mechanisms to Heal Chronic Wounds with a Multifunctional Wound Dressing”, Molecular Pharmaceutics, July 2021.
JoAnn Manson, MD, DrPH, MACP, Scientific Advisor
- “Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women”, Circulation, February 2021.
- “Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women’s Health Initiative”, Journal of the American Heart Association, February 2021.
- “Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment”, Endocrine Reviews, April 2021.
- “Women’s Health — Traversing Medicine and Public Policy”, New England Journal Of Medicine, June 2021.
Leena Mittal, MD, Director of the Women’s Mental Health Fellowship
- “Risk factors for depression, anxiety, and PTSD symptoms in perinatal women during the COVID-19 Pandemic”, Psychiatry Research, January 2021.
- “Can Telehealth Advance Professional Equity for Women in Medicine?”, Telemedicine and e-Health, March 2021.
Margo Nathan, MD, 2020 WHISPR Awardee
- “Predictors of irritability symptoms in mildly depressed perimenopausal women”, Psychoneuroendocrinology, April 2021.
Michelle O’Donoghue, MD, MPH
- “Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness”, Hypertension, May 2021.
Lydia Pace, MD, MPH, Director of Women’s Health Policy and Advocacy and the Global Women’s Health Fellowship
- “Should Women at Lower-Than-Average Risk of Breast Cancer Undergo Less Frequent Screening?”, Journal of the National Cancer Institute, January 2021.
- “Associations between insurance-related affordable care act policy changes with HPV vaccine completion”, BMC Public Health, February 2021.
- “Medicaid Payments For Immediate Postpartum Long-Acting Reversible Contraception: Evidence From South Carolina”, Health Affairs, February 2021.
- “Reproductive Injustice at the Southern Border and Beyond: An Analysis of Current Events and Hope for the Future”, Women’s Health Issues, April 2021.
- “ACA Mandate Led To Substantial Increase In Contraceptive Use Among Women Enrolled In High-Deductible Health Plans”, Health Affairs, April 2021.
- “Associations between ACA-related policies and a clinical recommendation with HPV vaccine initiation”, Cancer Causes & Control, July 2021.
Primavera Spagnolo, MD, PhD, Scientific Director, First.In.Women
- “A dimensional approach to functional movement disorders: Heresy or opportunity.”, Europe PMC, April 2021
- “Corticolimbic Modulation via Intermittent Theta Burst Stimulation as a Novel Treatment for Functional Movement Disorder: A Proof-of-Concept Study”, Multidisciplinary Digital Publishing Institute, June 2021.
Aleta Wiley, MPH, MSc, Director of Research Program Management
- “Predictors of irritability symptoms in mildly depressed perimenopausal women”, Psychoneuroendocrinology, April 2021.